Carregant...
Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies
Triple negative breast cancer (TNBC) is still an incurable disease despite the great scientific effort performed during the last years. The huge heterogeneity of this disease has motivated the evaluation of a great number of therapies against different molecular alterations. In this article, we revi...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5400659/ https://ncbi.nlm.nih.gov/pubmed/28108739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14731 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|